Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection

被引:0
|
作者
de Almeida Ponde, Roberio Amorim [1 ,2 ]
机构
[1] Coordenacao Anal & Pesquisas CAP, Gerencia Vigilancia Epidemiol Doencas Transmissive, Secretaria Estado Saude SES, Superintendencia Vigilancia Saude SUVISA GO, Goiania, Go, Brazil
[2] Rua 136 Qd F44 Lt 22-24 Ed Cesar Sebba Setor Sul, BR-74093250 Goiania, Go, Brazil
关键词
HBV markers; Sensitivity and specificity; Clinical classification; Case definition; Epidemiological surveillance; ACUTE EXACERBATION; BLOOD-DONORS; UNDERLYING MECHANISMS; VIRAL-HEPATITIS; HBSAG ASSAYS; SERUM HBSAG; DIAGNOSIS; MUTATIONS; DNA; DIFFERENTIATION;
D O I
10.1007/s11033-025-10278-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis B virus surface antigen (HBsAg), IgM and IgG antibodies to hepatitis B virus core antigen (anti-HBcIgM and anti-HBcIgG) comprise serological markers of hepatitis B virus (HBV) infection of great importance in the epidemiological surveillance of hepatitis B, since they have been routinely considered for classifying the acute and chronic clinical forms of HBV infection. This classification is established according to the expression and dynamics of these markers in the infected person's bloodstream, which serves as the basis for the differential diagnosis between the two clinical entities. However, in certain circumstances, both acute and chronic infection, the detection of these markers may not occur in the bloodstream, favoring the occurrence of atypical serological profiles of infection, and compromising the correct infection clinical classification. In addition, the complex and varied nature of hepatitis B serological profiles may compromise the health professional's ability to analyze the case and, thus, correctly classify the infection's clinical form. Since the expression of these markers in the bloodstream occurs dynamically, with consequent changes in the patient's serological profile as he progresses towards recovery or chronicity, the diagnosis of acute or chronic infection may also be compromised, if it is established based on the collection of a single sample and without knowing the patient's clinical history and their epidemiological antecedents. This manuscript addresses the sensitivity and specificity of HBsAg, anti-HBcIgM, and anti-HBcIgG serological markers detection in the clinical classification of HBV infection and in the epidemiological surveillance of hepatitis B. This review is covering the clinical and epidemiological interpretations of the markers in and of themselves, not in reference to any specific assays.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors
    Karimi, Gharib
    Zadsar, Maryam
    Vafaei, Nasrin
    Sharifi, Zohreh
    FalahTafti, Mohammad
    VIROLOGY JOURNAL, 2016, 13
  • [42] Risk Factors of Isolated Antibody Against Core Antigen of Hepatitis B Virus: Association With HIV Infection and Age but not Hepatitis C Virus Infection
    Liang, Shiou-Haur
    Chen, Tai-Jui
    Lee, Susan Shin-Jung
    Tseng, Fan-Chen
    Huang, Chun-Kai
    Lai, Chung-Hsu
    Chiou, Chou-Ping
    Wang, Jiun-Ling
    Chung, Hsing-Chun
    Lin, Jiun-Nong
    Kuo, Yi-Chi
    Lin, Hsi-Hsun
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (02) : 122 - 128
  • [43] Comparison of two immunoassays for quantification of hepatitis B surface antigen in Chinese patients with concomitant hepatitis B surface antigen and hepatitis B surface antibodies
    Liu, Weiwei
    Hu, Yao
    Yang, Yannan
    Hu, Tingting
    Wang, Xinyu
    ARCHIVES OF VIROLOGY, 2015, 160 (01) : 191 - 198
  • [44] Surface antigen-negative hepatitis B virus infection in Dutch blood donors
    Lieshout-Krikke, R. W.
    Molenaar-de Backer, M. W. A.
    van Swieten, P.
    Zaaijer, H. L.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (01) : 69 - 77
  • [45] Performance Evaluation of New Automated Hepatitis B Viral Markers in the Clinical Laboratory Two Quantitative Hepatitis B Surface Antigen Assays and an HBV Core-Related Antigen Assay
    Park, Yongjung
    Hong, Duck Jin
    Shin, Saeam
    Cho, Yonggeun
    Kim, Hyon-Suk
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (05) : 770 - 777
  • [46] Performance Evaluation of Four Dominant Anti-Hepatitis B Core Antigen (HBcAb) Kits in Japan for Preventing de novo Hepatitis B Virus (HBV) Infection
    Kobayashi, Eiji
    Deguchi, Matsuo
    Kagita, Masanori
    Yoshioka, Nori
    Kita, Mifumi
    Asari, Seishi
    Suehisa, Etsuji
    Hidaka, Yoh
    Iwatani, Yoshinori
    CLINICAL LABORATORY, 2015, 61 (1-2) : 77 - 85
  • [47] Safety of Tumor Necrosis Factor α Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative/Anti-Hepatitis B Core Antigen Positive) With Rheumatic Diseases
    Caporali, R.
    Bobbio-Pallavicini, F.
    Atzeni, F.
    Sakellariou, G.
    Caprioli, M.
    Montecucco, C.
    Sarzi-Puttini, P.
    ARTHRITIS CARE & RESEARCH, 2010, 62 (06) : 749 - 754
  • [48] Correlation of the content of hepatitis B core antigen in peripheral blood mononuclear cells with HBV virus load
    Peng, Yanzhong
    Xiong, Xiaojia
    Tong, Xindeng
    Li, Min
    Yang, Xifei
    Hu, Guoxin
    Geng, Yijie
    Li, Jianxin
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 85 (02) : 154 - 158
  • [49] Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia
    Bubonja-Sonje, Marina
    Peruc, Dolores
    Abram, Maja
    Mohar-Vitezi, Bojana
    ANNALS OF HEPATOLOGY, 2024, 29 (01)
  • [50] Monitoring by viral load and quantitative hepatitis B surface antigen in patients with hepatitis B virus infection receiving immunosuppressive therapy
    Yu, Hsien-Chung
    Tseng, Jui-Cheng
    Lu, Ling-Ying
    Hu, Jwi-Chieh
    Chen, Yan-Hua
    Hsu, Chiao-Lin
    Wu, Pin-Chieh
    Mar, Guang-Yuan
    Lin, Kung-Hung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (01) : 107 - 113